salesexhibits

4 results found.

Top Stocks matching your search for "sales exhibits"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
DRIO

DarioHealth Corp

-25.48%

$5.77 - $4.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 6, 2023

$DRIO "Based on our expected preliminary resu... See more

Dec, 9, 2022

376M annual sales, profitable, yet trades at 92M market cap!

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
GOOD

Gladstone Commercial Corp

-28.20%

$16.70 - $11.99

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 7, 2023

$GOOD https://www.stockilluminati.com/good/news.ph... See more

Dec, 13, 2022

$GOOD https://www.stockilluminati.com/good/news.ph... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 23, 2022

I have done the modeling of sales on this, and cur... See more

Dec, 21, 2022

$MDGL I see absolutely no issues with the equity sale arrangement.

DRIO

DarioHealth Corp

-25.48%

$5.77 - $4.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 6, 2023

$DRIO "Based on our expected preliminary results, we delivered higher revenues on lower spend, demonstrating that our strategy of moving from B2C to B2B sales channels is working and is the value maximizing path for the Company.

Dec, 9, 2022

376M annual sales, profitable, yet trades at 92M market cap!

Nov, 18, 2022

$DRIO Sales growth is impressive, and B2B strategy seems to be working.

Nov, 18, 2022

Thus, growth in the B2B segment easily offset the YoY decline in B2C sales, and was 63.5% of turnover in Q3, up from 46% last year.

Nov, 16, 2022

Sales growth momentum, new account wins, & accelerating margin improvement are all impressive.

Nov, 9, 2022

DIRT CHEAP at <1x sales for stellar growth + inflecting margins and a clear M&A target.

GOOD

Gladstone Commercial Corp

-28.20%

$16.70 - $11.99

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 23, 2022

I have done the modeling of sales on this, and current valuation is extremely attractive. Bullish!

Dec, 21, 2022

$MDGL I see absolutely no issues with the equity sale arrangement.

Dec, 21, 2022

but if it does, buy buy buy.. $159m ATM $100m stock sale $50m pulled from the existing credit facility